Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease
-
- Kosei Hirata
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Kiwamu Matsuoka
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Kenji Tagai
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Hironobu Endo
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Harutsugu Tatebe
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Maiko Ono
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Naomi Kokubo
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Asaka Oyama
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Hitoshi Shinotoh
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Keisuke Takahata
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Takayuki Obata
- Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Masoumeh Dehghani
- Physical Sciences, Sunnybrook Research Institute Toronto Canada
-
- Jamie Near
- Physical Sciences, Sunnybrook Research Institute Toronto Canada
-
- Kazunori Kawamura
- Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Ming‐Rong Zhang
- Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Hitoshi Shimada
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Takanori Yokota
- Department of Neurology and Neurological Science Tokyo Medical and Dental University Tokyo Japan
-
- Takahiko Tokuda
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Makoto Higuchi
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
-
- Yuhei Takado
- Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
この論文をさがす
説明
<jats:sec><jats:title>Objective</jats:title><jats:p>Increasing evidence suggests that reactive astrocytes are associated with Alzheimer's disease (AD). However, its underlying pathogenesis remains unknown. Given the role of astrocytes in energy metabolism, reactive astrocytes may contribute to altered brain energy metabolism. Astrocytes are primarily considered glycolytic cells, suggesting a preference for lactate production. This study aimed to examine alterations in astrocytic activities and their association with brain lactate levels in AD.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The study included 30 AD and 30 cognitively unimpaired participants. For AD participants, amyloid and tau depositions were confirmed by positron emission tomography using [<jats:sup>11</jats:sup>C]PiB and [<jats:sup>18</jats:sup>F]florzolotau, respectively. Myo‐inositol, an astroglial marker, and lactate in the posterior cingulate cortex were quantified by magnetic resonance spectroscopy. These magnetic resonance spectroscopy metabolites were compared with plasma biomarkers, including glial fibrillary acidic protein as another astrocytic marker, and amyloid and tau positron emission tomography.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Myo‐inositol and lactate levels were higher in AD patients than in cognitively unimpaired participants (<jats:italic>p</jats:italic> < 0.05). Myo‐inositol levels correlated with lactate levels (<jats:italic>r</jats:italic> = 0.272, <jats:italic>p</jats:italic> = 0.047). Myo‐inositol and lactate levels were positively associated with the Clinical Dementia Rating sum‐of‐boxes scores (<jats:italic>p</jats:italic> < 0.05). Significant correlations were noted between myo‐inositol levels and plasma glial fibrillary acidic protein, tau phosphorylated at threonine 181 levels, and amyloid and tau positron emission tomography accumulation in the posterior cingulate cortex (<jats:italic>p</jats:italic> < 0.05).</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>We found high myo‐inositol levels accompanied by increased lactate levels in the posterior cingulate cortex in AD patients, indicating a link between reactive astrocytes and altered brain energy metabolism. Myo‐inositol and plasma glial fibrillary acidic protein may reflect similar astrocytic changes as biomarkers of AD. ANN NEUROL 2024;95:104–115</jats:p></jats:sec>
収録刊行物
-
- Annals of Neurology
-
Annals of Neurology 95 (1), 104-115, 2023-09-28
Wiley